Home » About Us » Vision & Mission

About Us

Vision & Mission

“Becoming a First Mover in AI-Driven Transformation
of Precision Medicine in Korea”

SEOUL NATIONAL UNIVERSITY
HOSPITAL
Center for
Precision
Medicine
Establish an All-in-One,
Hospital-Wide NGS
Analysis Hub Based on
WES and WTS
Provide Solutions to
Unmet Needs through
a Leading NGS Analysis
Platform
Establish Clinical-
Genomic Governance
and Expand SNUH
POLARIS
Build a Foundation for
Advanced Translational
Research Connecting AI
with Clinical Practice

Establish an All-in-One, Hospital-Wide NGS Analysis Hub Based on WES and WTS

  • Implement WETS to generate and accumulate 2,000 cases annually, combining paired WES of tumor tissue and blood with WTS of tumor tissue, with a target of 7,000 cumulative cases by 2028 ​
  • Maintain the current turnaround time (TAT) through standardized analysis workflows, implementation of virtual panels, and continuous testing and optimization of the WETS pipeline

Provide Solutions to Unmet Needs through a Leading NGS Analysis Platform

  • Continuously advance an end-to-end analysis platform based on ADRESS and SNUH POLARIS
  • Address unmet needs through the development and implementation of state-of-the-art analytical technologies, including CNV and gene expression analysis

Establish Clinical-Genomic Governance and Expand SNUH POLARIS

  • Continuously enhance SNUH POLARIS and regularly incorporate stakeholder feedback through its steering committee to establish and maintain clinical-genomic governance
  • Expand SNUH POLARIS across the Seoul National University Hospital network, including SNUH, SNUBH, SMG-SNU Boramae Medical Center, and Siheung Baegot SNUH

Build a Foundation for Advanced Translational Research Connecting AI with Clinical Practice

  • Continuously develop novel analytical technologies based on WES and WTS
  • Promote and facilitate AI-driven clinical research using WETS data

Establish an All-in-One, Hospital-Wide NGS Analysis Hub Based on WES and WTS

  • Implement WETS to generate and accumulate 2,000 cases annually, combining paired WES of tumor tissue and blood with WTS of tumor tissue, with a target of 7,000 cumulative cases by 2028
  • Maintain the current turnaround time (TAT) through standardized analysis workflows, implementation of virtual panels, and continuous testing and optimization of the WETS pipeline

Provide Solutions to Unmet Needs through a Leading NGS Analysis Platform

  • Continuously advance an end-to-end analysis platform based on ADRESS and SNUH POLARIS
  • Address unmet needs through the development and implementation of state-of-the-art analytical technologies, including CNV and gene expression analysis

Establish Clinical-Genomic Governance and Expand SNUH POLARIS

  • Continuously enhance SNUH POLARIS and regularly incorporate stakeholder feedback through its steering committee to establish and maintain clinical-genomic governance
  • Expand SNUH POLARIS across the Seoul National University Hospital network, including SNUH, SNUBH, SMG-SNU Boramae Medical Center, and Siheung Baegot SNUH

Build a Foundation for Advanced Translational Research Connecting AI with Clinical Practice

  • Continuously develop novel analytical technologies based on WES and WTS
  • Promote and facilitate AI-driven clinical research using WETS data